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Abstract In this short paper, we describe a novel
approach to both signiﬁcantly accelerate and optically
amplify ﬂuorescence-based immunoassays. Our ap-
proach utilizes metal-enhanced ﬂuorescence (MEF)
to intrinsically optically amplify ﬂuorescence signa-
tures, which, when combined with the use of low-
power microwaves to kinetically accelerate assays,
provides for both ultrafast and ultrabright immuno-
assays. Surprisingly, the use of low-power microwaves
and silver nanostructures provides for localized heat-
ing, concentrating the effect to the particles themselves
as compared to the generic heating of the high
dielectric assay ﬂuid. We have subsequently applied
our microwave-accelerated MEF approach to the
detection of myoglobin, where its rapid quantiﬁcation
is paramount for the clinical assessment of an acute
myocardial infarction.
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Abbreviations
AMI acute myocardial infarction
SiFs silver-island ﬁlms
SEF surface-enhanced ﬂuorescence
MAMEF microwave-accelerated metal-enhanced
ﬂuorescence
MEF metal-enhanced ﬂuorescence
Mw low-power microwaves
Myo myoglobin
RDE radiative decay engineering
Introduction
Cardiovascular diseases are among the leading causes
of mortality in developed countries. It is widely
recognized that several cardiac markers should be
used for the assessment of a myocardial infarction,
such as myoglobin, troponin I, troponin T, and CK-MB
[1–3]. While not cardiac speciﬁc, myoglobin is one of
the very early markers that increases in concentration
directly after an acute myocardial infarction (AMI)
[4–8] and is therefore a suitable marker for rapid
diagnosis using our new microwave-accelerated metal-
enhanced ﬂuorescence (MAMEF) approach, which
offers an ultrarapid and sensitive platform for immu-
noassays [9,10].
There still remains some debate in the literature
today about the value distinguishing between a normal
and elevated biomarker level [1–8], with the different
markers being present at different levels both before
and after the onset of an AMI. For myoglobin, the
cutoff value is approximately 100 ng/ml [11], although
some reports of even higher cutoff levels of 200 ng/ml
have been reported [12,13]. Higher limits for myoglo-
bin are often considered because of the fact that
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Springermyoglobin is less speciﬁc as compared to other cardiac
markers, its level known to ﬂuctuate and be elevated,
not only after an AMI, but also because of other
factors such as muscular trauma or renal disorder [11].
In a recent paper by our laboratory [9], we have
demonstrated MAMEF on a model protein system.
MAMEF couples the beneﬁts of MEF, such as
increased signal intensities [14–20] and enhanced
ﬂuorophore photostabilities [14–20], with the use of
low-power microwaves to kinetically accelerate assays
and immunoassays [9,10]. This recent ﬁnding has
profound implications and applications in clinical
sense. First, the MEF phenomenon allows for much
more sensitive assays to be developed, as demonstrat-
ed by our laboratories on many occasions [14,16,17],
and second, the combination of low-power microwaves
to kinetically accelerate assays signiﬁcantly reduces an
immunoassays’ run time. Therefore, MAMEF pro-
vides for ultrafast and ultrabright immunoassays to be
realized.
There are a few medical conditions where the
results of an immunoassay are required instantly, such
as the diagnosis of an AMI. In a typical hospital
setting, a myoglobin immunoassay is usually run on a
serum (after blood separation) and can take >15 min
to kinetically run, the entire cardiac marker screening
process taking anywhere from 30 to 60 min [1–8].
Subsequently, in this short paper, we show how the
MAMEF approach can be applied to the rapid and
sensitive detection of myoglobin within 20 s, poten-
tially even in whole blood. The MAMEF assay shown
here is >10 times more sensitive and >90-fold more
rapid than an identical control assay run on a glass
microscope slide and one that is typically employed in
clinical settings. In addition, the signal-to-noise ratio of
our immunoassay system is $100-fold greater than
backgroundat100 ng/mlmyoglobin,whichisthe typical
clinical cutoff level for the assessment of an AMI.
Experimental
Myoglobin immunoassays were performed in a sand-
wich format as described previously, with a few
modiﬁcations [21], and as shown in Figure 1. In this
regard, slides were noncovalently coated with a
capture anti-myoglobin antibody at room temperature.
The glass/silver-island ﬁlms (SiFs) surfaces were
blocked with bovine serum albumin to minimize the
nonspeciﬁc interaction of the antibodies and myoglo-
bin with the surfaces. These surfaces were then
incubated with myoglobin antigen (100 ng/ml) at room
temperature (the clinical cutoff level for myoglobin
[12,13]) and then used for endpoint measurements.
The endpoint measurements were performed by incu-
bating the antigen-coated surfaces in a solution of
Alexa 647-labeled anti-myoglobin antibody for 30 min
at room temperature or by microwaving the antigen-
coated surfaces with Alexa 647-labeled anti-myoglobin
antibody for 20 s. Fluorescence measurements were
performed by collecting the emission intensity through
a long pass ﬁlter perpendicular to the assay surface,
after total-internal reﬂection evanescent wave excita-
tion [21], using a 650-nm diode laser and a Fiber Optic
Spectrometer (HD2000) from Ocean Optics, Inc.
(Figure 2). A detailed description of the microwave
cavity and its temperature calibration and the use of a
Bblack body^ to control (tune) surface microwave
power and therefore the degree of heating has been
published elsewhere [9].
Alexa 647-labeled
anti-Myoglobin 
Antibody
Capture anti-
Myoglobin  
Antibody
SiFs
BSA
Myoglobin 
Figure 1. Microwave-acceler-
ated metal-enhanced ﬂuores-
cence myoglobin
immunoassay.
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Figure 3 shows the plasmon absorption spectra of SiFs
(dry), both before and after low-power microwave
heating for 30 s. The microwave cavity power was
$140 W, which is the same as used in the myoglobin
assay discussed later, and is of a similar power used by
others for immunostaining [22,23]. Figure 3 shows that
the microwaves and heating had no effect on the
surface plasmon absorption of the SiFs, indicating no
structural or surface-silver shape changes, where the
surface plasmon absorption is well known to be
characteristic of the shape of the nanoparticles
[24,25]. In addition, no sparking was evident from the
silvered surfaces, a known consequence of surface
charge buildup and dissipation for large nonwave-
length-sized particles or continuous surfaces [26]. This
ﬁnding is consistent with other ﬁndings by our
laboratories for silver nanostructures in 2.45-GHz
microwave cavities [9,10].
To demonstrate the utility and clinical relevance of
our new MAMEF approach for myoglobin detection,
we constructed a two-stage assay as shown in Figure 1.
First, the assay surface is prepared on both glass and
silvered glass substrates, where the glass substrate is
used as a control sample by which to compare the
usefulness of the silver nanostructures. Myoglobin (100
ng/ml) was subsequently washed over the assay surface
followed by incubation of the anti-myoglobin antibody
labeled Alexa 647 ﬂuorophore. Figure 4 shows the
emission spectra of the labeled Alexa 647 from both
the glass and silvered glass regions of the slide, after
the anti-myoglobin had been incubated at room
temperature for 30 min. A careful investigation of the
system has shown that the assay was $95% kinetically
x-y stage
Laser
Fiber Optic 
Right Angle Prism
Filter
Holder
Sample
Figure 2. Total-internal reﬂection ﬂuorescence geometry for
myoglobin assessment.
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Figure 3. Absorption spectrum of silver-island ﬁlms (SiFs) both
before and after exposure to low-power microwaves.
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Figure 4. Emission spectrum of Alexa 647 on both SiFs and glass
after 30-min incubation (top) and normalized to the ﬂuorescence
emission on glass (bottom). The spectra are the mean of ﬁve
measurements on the respective surfaces.
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Plasmonics (2006) 55complete after 30-min incubation at 20-C. From
Figure 4 (top), we can see an $7.5-fold increase in
Alexa 647 emission on the silvered surface, as com-
pared to the glass control, where the spectra shown are
the mean of ﬁve separate surface measurements. It
should be noted that both the glass and silvered
portions of the slide had an identical surface coverage
of the capture anti-myoglobin antibody as has been
shown by our laboratories with various different
protein systems [14–20]. Figure 4 (bottom) shows the
normalized spectra, demonstrating that the spectral
properties are preserved on both the silver and glass
substrates.
Figure 5 (top) shows the combined effect of both
low-power microwave heating and the optical ampliﬁ-
cation due to silver for an identical assay as shown in
Figure 4. Interestingly, the assay yields an almost
identical ﬁnal emission intensity ($3000 au) after 20-s
microwave heating, as compared to a 30-min room
temperature incubation (cf. Figure 4, top). In addition,
the silver still maintains its properties for optically
enhancing the Alexa 647 ﬂuorescence because of
an intrinsic system radiative rate modiﬁcation [27].
Figure 5 (bottom) shows again that the properties of
the Alexa 647 are maintained. This result clearly
demonstrates the applicability of low-power micro-
waves to kinetically accelerate assays, coupled with
MEF, to optically enhance ﬂuorescence signatures. In
this immunoassay, the use of SiFs and MAMEF
provides for a 12-fold increase in signal, which can be
translated to an increased 12-fold assay sensitivity (i.e.,
a 12-fold potentially lower myoglobin concentration
detection limit), whereas the use of microwaves to
facilitate mass protein transport to the surface pro-
vides for an $90-fold decrease in the assay run time.
A close inspection and comparison of Figures 4 and
5 (top) reveals that the rapidity of the assay is not
equal on both the glass and silver substrates. After 30-
min incubation (Figure 4, top), the glass assay has a
maximum emission intensity of about 400 au at 675
nm. In comparison, after 20-s microwave heating
(Figure 5, top), the emission intensity on the glass
control is <400 au. This trend has also been observed
in other recent MAMEF papers by us [9,10]. Whereas
this decrease lends itself to a larger enhancement ratio
after microwave heating, i.e., 12 vs. 7.5, we believe that
this effect is a result of the preferential local heating
around the silver nanostructures [26], rapidly acceler-
ating mass transport from the solution to the surface.
Our detailed recent microwave calibration studies [9]
have shown that, under the conditions employed here,
only an $8-C bulk assay temperature jump occurred,
which cannot account for the 90-fold increase in assay
rapidity, further supporting our notion of localized
heating. In addition, others have reported the rapid
heating of metallic particles in microwave ﬁelds,
supporting our observations [26].
Nonspeciﬁc assay absorption
To ascertain the role of microwaves on the extent of
nonspeciﬁc assay absorption, we undertook several
control experiments (Figure 6).
From Figure 6 (top), we can see the emission
intensity of the complete assay after only 30-s incuba-
tion, with no microwave heating (100 ng/ml myoglo-
bin). Interestingly, the total emission intensity is quite
low, as compared to 20-s microwave heating (Figure 5,
top). When the assay is incubated with Alexa 647
anti-myoglobin but with no myoglobin in the sandwich
immunoassay, then little, if any, nonspeciﬁc absorption
could be observed (Figure 6, middle). Furthermore,
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Figure 5. Emission spectrum of Alexa 647 on both SiFs and glass
after 20-s low-power microwave heating (top) and normalized to
the ﬂuorescence emission on glass (bottom). The spectra are the
mean of ﬁve measurements on the respective surfaces.
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myoglobin), only a very small amount of nonspeciﬁc
absorption could be observed (<100 au; Figure 6,
bottom). Therefore, we estimate that the contribution
of nonspeciﬁc absorption toward the total ﬂuorescence
emission after 20-s microwave heating is less than 3%
(cf. Figure 5, top and Figure 6, bottom).
Assay/ﬂuorophore photostability
Fluorophore or analyte photostability is a primary
concern in many applications of ﬂuorescence spectros-
copy, particularly in platform assays and in single
molecule studies [28,29]. In our recent reports, we
have shown that a reduced ﬂuorescence lifetime of
ﬂuorescent species in close proximity to silver nano-
structures affords for an increased ﬂuorophore photo-
stability [14–20]. Subsequently, we investigated the
combined effect of both constant exposure to 650-nm
laser light (<1 mW) and low-power microwaves on the
ﬂuorophore emission. Figure 7 shows the emission
intensity value of Alexa 647 from a 100-ng/ml myoglo-
bin immunoassay, which was ﬁrst microwave-heated to
completion for 30 s. The emission from the silvered
surface is at least six times greater than on glass. After
cumulative and continued exposure to microwaves, the
emission intensities on both glass and silver can be seen
to be constant, indicating that low-power microwaves
do not perturb the ﬂuorophore. It should be noted that
the assay volume on the surface was 50 ml, which did
not dry during the microwave heating. A detailed
description of the microwave procedure and cavity
calibration can be found elsewhere [9].
Beneﬁts of the MAMEF platform in clinical sensing
In this short paper, we have shown an approach for the
fabrication of low-cost ultrafast and ultrarapid clinical
assays. This new approach addresses two of the main
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Figure 6. Control experiments: emission spectrum of Alexa 647
on both SiFs and glass after 30-s incubation at room temperature
(with myoglobin; top), after 30-min incubation at room temper-
ature (no myoglobin; middle), and after 30-s low-power micro-
wave heating (no myoglobin; bottom).
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Figure 7. Emission intensity of Alexa 647 on both SiFs and glass
after cumulative low-power microwave heating. lex = 650 nm.
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Plasmonics (2006) 57bottlenecks with current immunoassays, namely, assay
rapidity and sensitivity. Our new MAMEF myoglobin
immunoassay has several advantages including the
following:
& The MEF phenomenon has been shown to enhance
ﬂuorescence signatures up to several thousand
folds [30]. Hence, high sensitivity detection for
troponins I and T can readily be envisaged, which
have clinical cutoff values $100-fold lower than for
myoglobin.
& A whole variety of silvered surfaces can be readily
prepared [14–20] and also on a variety of sub-
strates, such as plastics [31].
& The evanescent wave mode of excitation used in this
paperstronglysuggeststhattheassayscanbeusedin
whole blood without the need for serum separation,
i.e., enhanced localized excitation above the silver.
In this regard, our group has recently reported the
detection of biospecies in whole blood using silver-
ampliﬁed evanescent wave excitation [21].
& The low-power microwaves used here do not
perturb the silver nanostructures and do not
produce arching, which is commonly observed for
metallic objects in microwave cavities [26].
& Low-power microwaves substantially increase the
rapidity of the assays but not denature the assay
proteins,asshowninarecentpaperbyourgroup[9].
Conclusions
In this paper, we have demonstrated a model myoglo-
bin immunoassay for the potential rapid and sensitive
detection of a myocardial infarction. The assay dem-
onstrated can readily detect 100 ng/ml of myoglobin in
20 s, from only 50 ml of ﬂuid. The signal-to-noise ratio
of the assay is about 100 times above the background
for 100 ng/ml myoglobin, which suggests that this
approach could equally be used to detect other more
speciﬁc cardiac markers, such as either troponin I or T,
which have clinical cutoff levels of only a few nano-
grams per milliliter. Further studies are underway in
this regard and will be reported in due course.
Finally, given the low cost and simplicity of the
MAMEF technology, coupled with the fact that it
potentially provides a generic platform for sensing both
clinical analytes and bioterrorism agents, we then en-
visage that this technology will eventually ﬁnd general
use in the form of disposable one-time use devices for:
(1) future home tests kits for clinical assessment and
safeguard, such as for myocardial infarction and the
related self-diagnosis of chest pains; (2) use by ambu-
lance or care workers for the rapid and sensitive
diagnosis of various conditions; and (3) a disposable
ﬁeld-use MAMEF test stick utilized by ﬁrst responders,
where the rapid, sensitive, and speciﬁc detection of
bioagents is of immense national importance.
Acknowledgments This work was supported by the NIH
GM070929 and the National Center for Research Resources,
RR008119. Partial salary support to CDG from UMBI/MBC is
also acknowledged. We also thank Dr. Evgenia Matveeva at the
Center for Fluorescence Spectroscopy for help with the prepa-
ration of the immunoassays.
References
1. Ellenius J, Groth T, Lindahl B, Wallentin L (1997) Early
assessment of patients with suspected acute myocardial
infarction by biochemical monitoring and neural network
analysis. Clin Chem 43:1919–1925
2. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker JF,
Kaplan AL, Schreiber DH, Tuttle RH, McNulty SE, Ohman
EM (2001) Bedside multimarker testing for risk stratiﬁcation
in chest pain units—the chest pain evaluation by creatine
kinase-MB, myoglobin, and troponin I (CHECKMATE)
study. Circulation 103:1832–1837
3. Storrow AB, Gibler WB (1999) The role of cardiac mark-
ers in the emergency department. Clin Chim Acta 284:187–
196
4. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J,
Wu AH (1999) Use of biochemical markers in acute coronary
syndromes. Clin Chem Lab Med 37:687–693
5. Woo J, Lacbawan FL, Sunheimer R, LeFever D, McCabe JB
(1995) Is myoglobin useful in the diagnosis of acute myocar-
dial-infarction in the emergency department setting. Am J
Clin Pathol 103:725–729
6. Tucker JF, Collins RA, Anderson AJ, Hess M, Farley IM,
Hagemann DA, Harkins HJ, Zwicke D (1994) Value of
serial myoglobin levels in the early diagnosis of patients
admitted for acute myocardial-infarction. Ann Emerg Med
24:704–708
7. Montague C, Kircher T (1995) Myoglobin in the early
evaluation of acute chest pain. Am J Clin Pathol 104:472–
476
8. Kilpatrick WS, Wosornu D, McGuinness JB, Glen AC
(1993) Early diagnosis of acute myocardial-infarction—
ck-mb and myoglobin compared. Ann Clin Biochem
30:435–438
9. Aslan K, Geddes CD (2005) Microwave-accelerated metal-
enhanced ﬂuorescence (MAMEF): a new platform technol-
ogy for ultra-fast and ultra-bright assays. Anal Chem
77(24):8057–8067
10. Aslan K, Geddes CD (in press) Microwave-accelerated
metal-enhanced ﬂuorescence (MAMEF): application to fast
and sensitive clinical assays. J Fluoresc
11. Matveeva E, Gryczynski Z, Gryczynski I, Malicka J,
Lakowicz JR (2004) Myoglobin immunoassay utilizing
directional surface plasmon-coupled emission. Anal Chem
76, 6287–6292
12. Castaldo AM, Ercolini P, Forino F, Basevi A, Vrenna L,
Castaldo P, Ambrosio VD, Castaldo A (1994) Eur J Clin
Chem Clin Biochem 32(5), 349–353
Springer
58 Plasmonics (2006)13. Hillis GS, Zhao N, Taggart P, Dalsey WC, Mangione A
(1999) Utility of cardiac troponin I, creatine kinase-MBmass,
myosin light chain 1, and myoglobin in the early in-hospital
triage of Bhigh risk’’ patients with chest pain. Heart 82(5):
614–620
14. Aslan K, Gryczynski I, Malicka J, Matveeva E, Lakowicz JR,
Geddes CD (2005) Metal-enhanced ﬂuorescence: an emerg-
ing tool in biotechnology. Curr Opin Biotechnol 16(1):55–62
15. Geddes CD, Lakowicz JR (2002) Metal-enhanced ﬂuores-
cence. J Fluoresc 12(2):121–129
16. Geddes CD, Aslan K, Gryczynski I, Malicka J, Lakowicz JR
(2005) In: Geddes CD, Lakowicz JR (eds) Topics in
Fluorescence in Fluorescence Spectroscopy, Kluwer Aca-
demic/Plenum Publishers, New York, USA, pp 401–448
17. Geddes CD, Aslan K, Gryczynski I, Malicka J, Lakowicz JR
(2004) In: Geddes CD, Lakowicz JR (eds) Review Chapter
for Annual Reviews in Fluorescence 2004, Kluwer Academ-
ic/Plenum Publishers, New York, USA, pp 365–401
18. Aslan K, Lakowicz JR, Geddes CD (2005) Rapid deposition
of triangular silver nanoplates on planar surfaces: application
to metal-enhanced ﬂuorescence. J Phys Chem B.
107(13):6247–6251
19. Aslan K, Leonenko Z, Lakowicz JR, Geddes CD, (2005)
Fast and slow deposition of silver nanorods on planar
surfaces: application to metal-enhanced ﬂuorescence. J Phys
Chem B 109(8):3157–3162
20. Geddes CD, Parfenov A, Roll D, Fang J, Lakowicz JR
(2003) Electrochemical and laser deposition of silver for
use in metal-enhanced ﬂuorescence. Langmuir 19(15):6236–
6241
21. Matveeva E, Gryczynski Z, Lakowicz JR, (2005) Myoglobin
immunoassay based on metal particle-enhanced ﬂuores-
cence. J Immunol Methods 302:26–35
22. Micheva KD, Holz RW, Smith SJ (2001) Regulation of
presynaptic phosphatidylinositol 4,5-biphosphate by neuro-
nal activity. J Cell Biol 154:355–368
23. Petrali JP, Mills KR (1998) Microanalysis 4:114–115
24. Link S, El-Sayed MA (1999) Spectral properties and
relaxation dynamics of surface plasmon electronic oscilla-
tions in gold and silver nanodots and nanorods. J Phys Chem
B 103:8410–8426
25. Kreibig U, Genzel L (1985) Surf Sci 156:678–700
26. Whittaker AG, Mingos DMP (1993) Microwave-assisted
solid-state reactions involving metal powders and gases. J
Chem Soc Dalton Trans 16:2541–2543
27. Aslan K, Leonenko Z, Lakowicz JR, Geddes CD (2005)
Annealed silver island ﬁlms for metal-enhanced ﬂuores-
cence. J Fluoresc 15(5):643–654
28. Lakowicz JR (1999). Principles of Fluorescence Spectrosco-
py. Kluwer, New York
29. Axelrod D, Hellen EH, Fulbright RM (1992) Total internal
reﬂection ﬂuorescence. In: Lakowicz JR (ed) In Topics in
Fluorescence Spectroscopy, Vol. 3: Biochemical Applica-
tions. Plenum Press, New York, pp 289–343
30. Parfenov A, Gryczynski I, Malicka J, Geddes CD, Lakowicz
JR (2003) Enhanced ﬂuorescence from ﬂuorophores on
fractal silver surfaces. J Phys Chem B 107(34):8829–8833
31. Aslan K, Badugu R, Lakowicz JR, Geddes CD (2005) Metal-
enhanced ﬂuorescence from plastic substrates. J Fluoresc
15(2):99–104
Springer
Plasmonics (2006) 59